State legislators in Pennsylvania are moving forward with updated regulations for the cannabis and hemp industries. A state Senate committee recently advanced a revised version of a key cannabis regulation bill. The updated legislation introduces new provisions specifically designed to align state law with newly established federal hemp guidelines.
Lawmakers on the Senate Law and Justice Committee voted to approve an amendment to Senate Bill 49. Introduced by State Senator Dan Laughlin, the bill originally focused on establishing a centralized regulatory body for medical cannabis. The new amendment expands this scope by addressing the shifting landscape of hemp-derived cannabinoids.
This legislative update directly responds to federal policy changes approved late last year that redefine legal hemp. By adjusting state statutes to mirror federal law, Pennsylvania legislators are attempting to close regulatory loopholes that have allowed certain hemp-derived products to proliferate.
I’ve amended SB 49 to align PA law with new federal hemp standards that close loopholes allowing intoxicating hemp products like Delta-8, Delta-10 and THCA to be sold with little oversight.
— Senator Dan Laughlin (@senatorlaughlin) March 16, 2026
The bill would also create a Cannabis Control Board.
Read more: https://t.co/lGBs1LZa11 pic.twitter.com/PcRPCRVY7J
Senate Bill 49 and the Cannabis Control Board
Before the recent amendments, Senate Bill 49 was already a significant piece of legislation for Pennsylvania. The primary goal of the bill is to create the Pennsylvania Cannabis Control Board. This new entity would take over the regulation of the state’s existing medical marijuana program, which is currently managed by the Pennsylvania Department of Health.
Supporters of the original bill argue that a dedicated regulatory board would provide more efficient oversight for medical cannabis businesses and patients. Furthermore, establishing this infrastructure now could prepare the state for the potential future legalization of adult-use recreational marijuana. Consolidating oversight into a single agency is viewed as a way to eliminate inconsistencies and enhance transparency across the industry.
What the Federal Standards Amendment Changes
The amendment recently adopted by the Senate Law and Justice Committee tackles the complex market of intoxicating hemp products. Following the passage of the 2018 Farm Bill, products containing cannabinoids like Delta-8 THC, Delta-10 THC, and THCA became widely available in convenience stores and smoke shops. Because these products were derived from hemp, they existed in a legal gray area that separated them from strictly regulated marijuana.
The new provisions added to Senate Bill 49 seek to ban the sale of most of these intoxicating hemp products. The amendment tightens the state’s definition of legal hemp, explicitly prohibiting products intended for human consumption that contain synthetically derived or naturally occurring intoxicating cannabinoids. This effectively removes the distinction that allowed these specific items to bypass the safety regulations applied to traditional medical cannabis.
The Influence of Federal Legislation
Pennsylvania’s legislative shift is a direct reaction to federal actions taken late last year. In November 2025, Congress passed H.R. 5371, a measure that significantly tightened the federal definition of hemp. The federal law restricts legal hemp products to a total of 0.4 milligrams per container of total THC or any other cannabinoids with similar effects.
State Senator Laughlin noted that updating Pennsylvania’s definition to match the federal government ensures that state laws remain consistent and enforceable, removing confusion for local authorities.
“As the federal government updates its definition of hemp, Pennsylvania needs to make sure our laws remain consistent and enforceable,” Laughlin said. “Amending Senate Bill 49 to mirror these federal changes helps close the same loopholes that allowed intoxicating hemp products to flood the marketplace with little oversight.”
Primary Objectives of the Regulatory Update
According to the lawmakers advancing the bill, bringing Pennsylvania law into alignment with federal standards serves a few specific functional purposes. The committee aims to address current market dynamics through the following goals:
- Unified Oversight: Transitioning all medical cannabis and hemp regulation under the umbrella of the newly formed Pennsylvania Cannabis Control Board.
- Consumer Safety: Establishing uniform testing and safety standards to prevent untested or potentially harmful synthetic products from reaching the retail market.
- Law Enforcement Clarity: Providing police departments and state regulators with clear, unambiguous guidelines to identify and remove illegal products from store shelves.
The Road Ahead for Pennsylvania Cannabis Law
The Senate Law and Justice Committee approved the amended version of Senate Bill 49 with a 10-1 vote on March 16th. Despite the strong committee support, the legislation still faces several hurdles before it can become law. The proposal remains with the committee and must undergo further review to secure a vote on the Senate floor before advancing to the House.
Business owners and consumers alike are watching the progression of this bill closely. Some local retailers have expressed concerns that a broad ban on hemp-derived products could negatively impact their businesses, especially those who source products transparently. On the other hand, advocates for strict regulation argue that clearing the market of unregulated synthetics is a necessary step for public health.
As lawmakers continue to debate the issue of adult-use legalization—a key priority in Governor Josh Shapiro’s recent budget proposals—Senate Bill 49 is an attempt to organize the state’s current cannabis industry.
